Drug Interactions between foscarbidopa / foslevodopa and racepinephrine
This report displays the potential drug interactions for the following 2 drugs:
- foscarbidopa/foslevodopa
- racepinephrine
Interactions between your drugs
racepinephrine foslevodopa
Applies to: racepinephrine and foscarbidopa / foslevodopa
Consumer information for this interaction is not currently available.
GENERALLY AVOID: Coadministration with foslevodopa may potentiate the cardiovascular effects of sympathomimetic agents (e.g., epinephrine, norepinephrine, isoproterenol, amphetamine). Additive increases in blood pressure and heart rate may occur due to enhanced sympathetic activity. However, data evaluating the interaction are not available.
MANAGEMENT: The use of levodopa with sympathomimetic agents should generally be avoided. If concomitant use is required, close monitoring of the cardiovascular system is recommended. Some authorities consider the coadministration of sympathomimetic agents and foslevodopa to be contraindicated (Canada).
Drug and food interactions
foslevodopa food
Applies to: foscarbidopa / foslevodopa
Alcohol can increase the nervous system side effects of foslevodopa such as dizziness, drowsiness, and difficulty concentrating. Some people may also experience impairment in thinking and judgment. You should avoid or limit the use of alcohol while being treated with foslevodopa. You may experience reduced effectiveness of foslevodopa in the presence of foods or enteral (tube) feedings with a high protein content. This may make the symptoms of Parkinson's disease worse. Talk with your doctor or nutrition counselor about the best foods to eat while you are taking this medication. Contact your doctor if your condition changes.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.